Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2023 · 10-Q
Revenue$11.79M$11.79M−1.7% vs Q2 2022 Net Income$39.78M$39.78M+83.5% vs Q2 2022 EPS Diluted$0.92$0.92+95.7% vs Q2 2022 Operating Cash Flowderived$50,496,000−11.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 8, 2023 · 39 d after period end